DrugDashboards

Potassium Phosphate

Potassium Phosphate · MONOBASIC POTASSIUM PHOSPHATE 224 mg/mL; DIBASIC POTASSIUM PHOSPHATE 236 mg/mL · Injection, Solution · Intravenous · Somerset Therapeutics, LLC

NDC 70069-0747-25 · 25 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Somerset Therapeutics Private Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$550.00
Reported to Texas DSHS · 2026 annual filing · Somerset Therapeutics, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$442,844
1,732 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $137.60 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
ANDA217726
TE code
AP
Approval date
Jul 11, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Potassium Phosphate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Somerset Therapeutics, LLCMONOBASIC POTASSIUM PHOSPHATE 224 mg/mL; DIBASIC POTASSIUM PHOSPHATE 236 mg/mLAug 26, 2026Sep 3, 2026
American Regent, Inc.POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mLAug 26, 2026Sep 2, 2026
Somerset Therapeutics, LLCMONOBASIC POTASSIUM PHOSPHATE 236 mg/mL; DIBASIC POTASSIUM PHOSPHATE 224 mg/mLJul 22, 2026Aug 21, 2026
American Regent, Inc.POTASSIUM PHOSPHATE, MONOBASIC 236 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 224 mg/mLJul 22, 2026Aug 19, 2026
Somerset Therapeutics, LLCDIBASIC POTASSIUM PHOSPHATE 236 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 224 mg/mLJul 15, 2026Jul 18, 2026
American Regent, Inc.POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Potassium Phosphate — NDC 70069-0747-25," retrieved September 3, 2026, https://drugdashboards.com/drug/70069074725.

Free to cite with attribution — see how the data is put together.